LSI Europe 26 announced a new panel featuring company leaders and regulatory experts discussing FDA and CMS working with emerging medtech companies.

Innovative startups, venture investing, and strategic acquisitions are among the most powerful forces for improving healthcare. But they rely on systems of the past. LSI was founded to help today's executives build, finance, and scale tomorrow's medical innovations. We published our first medtech report in 2006. Then we expanded into deeper market sizing, forecasting, and analysis. But this has always been the foundation of a bigger vision. In 2020, we launched our first Emerging Medtech Summit. Unlike trade shows, the summit was purpose-built for world-class executives and hosted in a world-class venue where they would love to do real business. Since 2022, the LSI Alumni have raised over $10.5B in capital transactions. Today, we're building something transformative: a global platform to access capital, insights, and expertise. One connected ecosystem of premium experiences, data solutions, and media that enables the industry to act smarter, faster, and with more impact. For too long, innovators, investors, and strategics alike in our $10 trillion global industry have been left to flail for trusted intelligence and meaningful relationships. We're changing that by reimagining how they connect, get deals done, and make decisions at every level. The future of healthcare will be built by those with the right relationships and the best intelligence, and LSI is leading the way to unlock it.